Analyst Ratings for Atea Pharmaceuticals (AVIR)
AVIR Rating Summary
AVIR Price Target Summary
- Highest: $7.00 (Morgan Stanley)
- Lowest: $7.00 (Morgan Stanley)
- Average: $7.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$7.00 (+22.8%)
* Over Last 12-Mos
Rating Score: 4 / 10
Percentile Rank: 39%
Rating Score: 4 / 10
Percentile Rank: 39%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/13/2024 | Morgan Stanley » Updated 8/13/2026 |
Matthew Harrison | Upgrade | Equalweight (Underweight) |
7.00 (6.00) |
3.37 (5.70) |
69.14% | Details |
| 8/10/2023 | JPMorgan | Eric Joseph | Downgrade | Underweight (Neutral) |
N/A (N/A) |
3.41 (5.70) |
67.16% | Details |
 |
||||||||
|
||||||||
|
||||||||
